Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists

Details for Australian Patent Application No. 2006274051 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Riemer, Claus; Spooren, Will; Gobbi, Luca Claudio; Hoener, Marius

Agent Spruson & Ferguson

Pub. Number AU-B-2006274051

PCT Pub. Number WO2007/012579

Priority 05106802.1 25.07.05 EP

Filing date 17 July 2006

Wipo publication date 1 February 2007

Acceptance publication date 22 March 2012

International Classifications

C07D 249/04 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/012579 Priority application(s): WO2007/012579

22 March 2012 Application Accepted

  Published as AU-B-2006274051

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274052-Use of tetrahydrobenzoxazines as stabilisers

2006274050-Aqueous-based and transparent coatings for marking substrates